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Pediatric patientsAbstract Background: Tonsillectomy is one of the most common surgery in pediatric and
bleeding is one of the most serious complications related to tonsillectomy. Tranexamic acid is a
plasminogen inhibitor which has been successfully used to control bleeding in a variety of surgeries.
Aim: The aim of the present study was to assess the effect of tranexamic acid on bleeding in
pediatric patients undergoing elective tonsillectomy.
Materials and methods: The present study included 225 patients classiﬁed into three groups:
(n= 75): Group A: The tranexamic acid was given after induction intravenously as 15 mg/kg over
10 min. Group B: The tranexamic acid was given after induction intravenously as 15 mg/kg over
10 min and continued infusion as 5 mg/kg/h during surgery. Group C (control group): The patients
did not receive tranexamic acid. The bleeding was assessed by the extent of blood loss using the
Boezaart blood grading scale, measuring blood in the suction jar, and by visual estimation of
4 · 4 gauze pads.
Results: The comparison of Boezaart blood grading scale and amount of blood loss was
insigniﬁcant between the three groups (p> 0.05).
Conclusion: The present study showed no effect of tranexamic acid in decreasing the tonsillectomy-
related bleeding and there is no complication related to tranexamic acid. We are recommending
other studies to measure the ﬁbrinolytic activity during tonsillectomy and its inhibition by tranex-
amic acid.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Tonsillectomy is one of the most common surgical procedures
performed in otolaryngology practice. Tonsillectomy-related
hemorrhage may occur intraoperatively or postoperatively.
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of surgery) and secondary hemorrhage (more than 24 h after
surgery, typically one week postoperative). Intraoperatively
bleeding is controlled at the time of surgery. Primary hemor-
rhage usually requires return to theater (80% of cases), while
the return to theater rate is less for secondary hemorrhage
(17%) [1].
Tranexamic acid is a synthetic lysine analogue, producing
an antiﬁbrinolytic effect by the reversible blockade of lysine
binding sites on plasminogen molecules. This inhibits the con-
version of plasminogen to plasmin on the surface of the ﬁbrin
[2,3]. It has been used in cardiac, orthopedic and urological
surgery to reduce perioperative blood loss [4], and to reduce
the need for blood transfusion with no increased risk of throm-
boembolic complications [5]. It has also been used topically as
a mouth wash following dental and oral surgery [6].
The aim of the present study was to assess the role of
tranexamic acid in pediatric patients undergoing elective ton-
sillectomy. The primary outcome was measuring the amount
of blood loss and the extent of blood loss.
2. Methods and patients
After approval from the local ethics committee and obtaining
written informed parental consent in King Fahad military hos-
pital, Khamis Mushait, Saudi Arabia, we studied 225 children
(ASA physical status I–II) undergoing elective tonsillectomy
without adenoidectomy. The indications of tonsillectomy were
recurrent acute tonsillitis.
Exclusion criteria included patients with liver or kidney
dysfunction or patients with inherited coagulopathy or preop-
erative use of anticoagulant therapy or abnormal coagulation
proﬁles or allergy to tranexamic acid or neurologic or psychi-
atric disease. The present study included 225 patients classiﬁed
into three groups (each = 75):
Group A: The tranexamic acid was given after induction
intravenously as 15 mg/kg (single bolus dose) over 10 min.
Group B: The tranexamic acid was given after induction
intravenously as 15 mg/kg over 10 min and continued infu-
sion as 5 mg/kg/h during surgery.
Group C (control group): The patients did not receive
tranexamic acid.
2.1. Anesthetic technique
After attaching the monitors to patients, the anesthetic induc-
tion was started either inhalationally (sevoﬂurane) or intra-
venously (ketamine) in addition to fentanyl (2 lg/kg) and
rocuronium (0.6 mg/kg) and after tracheal intubation, the
patients were ventilated mechanically and the anesthesia was
maintained with sevoﬂurane (2–3%) and oxygen/air mixture
(50%). At the end of surgery, the muscle relaxant was reversed
and the patients were extubated.
2.2. Surgical technique
The techniques of tonsillectomy can be broadly divided into
two major categories: extracapsular (total tonsillectomy,
subcapsular) and intracapsular (partial tonsillectomy).Extracapsular tonsillectomy involves dissecting lateral to the
tonsil in the plane between the tonsillar capsule and the pha-
ryngeal musculature, and the tonsil is generally removed as a
single unit. The most common extracapsular techniques use
a ‘‘cold’’ knife (sharp dissection), bipolar cautery (or bipolar
scissors). Extracapsular techniques are used for patients under-
going tonsillectomy as a result of tonsillitis or peritonsillar
abscess [7]. In the present study, extracapsular technique is
used for all cases.
2.3. Monitoring of patients
Heart rate, noninvasive arterial blood pressure, arterial oxygen
saturation, end-tidal carbon dioxide, and body temperature
were recorded every 5 min during surgery. At the end of each
procedure, the extent of blood loss was assessed using the
Boezaart blood grading scale (Table 1) [8].
2.4. Calculation of blood loss
For measuring blood in the suction jar, the ﬂuid in the suction
jar was poured into a measuring cylinder and the quantity of
ﬂuid present before the surgery was subtracted. The lower edge
of the ﬂuid meniscus after the foam had settled, was considered
for the readings, also by visual estimation of 4 · 4 gauze pads,
if mildly moist from 8 ml, moderately moist from 10 ml and
completely moist from 12 ml blood [9–11].
2.5. Sample size calculation
Power analysis was performed usingChi square test for indepen-
dent samples on frequency of patients complaining of
tonsillectomy-related hemorrhage because it was the main out-
comevariable in the present study.Apilot studywas donebefore
starting this studybecause there are no clear data in the literature
for the incidence of tonsillectomy-related hemorrhage with
tranexamic acid administration. The results of the pilot study
showed incidence of postoperative agitation of 10% in tranex-
amic acid group, and 30% in control group. Taking power 0.8
and alpha error 0.05, a minimum sample size of 72 patients
was calculated for each group. A total of patients in each group
75 were included to compensate for possible dropouts.
2.6. The statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), and frequencies (number of cases).
Comparison of numerical variables between the study groups
was done using one-way analysis of variance (ANOVA) test
with post hoc multiple 2-group comparisons. Exact test was
used instead when the expected frequency is less than 5. p val-
ues less than 0.05 were considered statistically signiﬁcant. All
statistical calculations were done using computer programs
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) version 15 for Microsoft Windows.3. Results
The study included 225 patients randomized to three groups
and all patients had completed the study (Fig. 1). There were
Table 1 Quality of surgical ﬁeld Boezaart et al. [8].
Grade Assessment
0 No bleeding, cadaveric conditions
1 Slight bleeding, no suctioning required
2 Slight bleeding, occasional suctioning required
3 Slight bleeding, frequent suctioning required. Bleeding
threatens surgical ﬁeld a few seconds after the suction is
removed
4 Moderate bleeding, frequent suctioning required, and
bleeding that threatens surgical ﬁeld directly after suction
is removed
5 Severe bleeding, constant suctioning required. Bleeding
appears faster than can be removed by the suction; surgical
ﬁeld severely threatened, and surgery usually not possible
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heart rate, mean arterial blood pressure, temperature and
duration of surgery (p> 0.05) (Table 2).
The comparison of blood loss between the three groups is
insigniﬁcant and the mean was 46.56 ± 5.92 in Group AFigure 1 Flow diagram of the progress through the phases of a pa
allocation, follow-up, and data analysis).patients, 47.07 ± 5.96 in Group B patients and 47.17 ± 5.36
in Group C patients (p= 0.691).
The comparison of blood grading scale (grades 1, 2, 3, 4,
and 5) between the three group is insigniﬁcant (p> 0.05)
(Table 2). The incidence of primary bleeding (<24 h after
surgery), between the three groups was insigniﬁcant
(p> 0.05) (Table 2). There was no secondary bleeding in the
present study.
4. Discussion
The present study showed no effect of single intravenous dose
or infusion of tranexamic acid to decrease the incidence of
bleeding and blood loss during tonsillectomy in comparison
with the control group and the cause is not clear in spite of
many papers showed the effectiveness of tranexamic acid in
decreasing surgical bleeding.
There are some studies supporting our results. Brum et al.,
found in a double-blind, randomized placebo-controlled trial
included ninety-ﬁve children who underwent adenotonsillec-
tomy, that there is no beneﬁt of using the tranexamic acidrallel randomised three groups (that is, enrollment, intervention
Table 2 Data of patients (data are presented as mean ± SD, number).
Variable Group A (n= 75) Group B (n= 75) Group C (n= 75) p-value
Age (year) 7.14 ± 2.35 7.00 ± 2.32 7.10 ± 2.45 0.346
Weight (kg) 17.05 ± 3.92 17.00 ± 3.84 16.96 ± 3.97 0.557
Gender (number of patients) Male 36 40 38 0.870
Female 39 35 37 0.765
Heart rate (bpm) 84.10 ± 11.56 82.,00 ± 11.30 83.15 ± 12.04 0.954
MAP (mmHg) 76.04 ± 6.46 77.07 ± 6.34 78.27 ± 6.25 0.969
Temperature (C) 36.76 ± 0.36 36.45 ± 0.73 36.57 ± 0.53 0.484
Duration (min) 39.01 ± 7.58 39.18 ± 7.34 38.87 ± 7.28 0.895
Blood loss (ml) 46.56 ± 5.92 47.07 ± 5.96 47.17 ± 5.36 0.691
Blood grading scale Grade 0 – – –
Grade 1 35 32 36 0.844
Grade 2 24 27 25 0.546
Grade 3 10 8 7 0.308
Grade 4 4 5 6 0.356
Grade 5 2 3 1 0.245
Primary bleeding (number of patients) 1 2 1 0.649
Secondary bleeding (number of patients) – – –
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dren [12].
Other two results documented that tranexamic acid is not
effective in decreasing the bleeding associated with surgery
but one study was done in hip surgery [13], and one study done
for third molar extraction [14]. Another study showed no sig-
niﬁcant beneﬁt from the routine use of tranexamic acid during
tonsillectomy but this study was done in adult patients [15].
A systemic review and meta-analysis of the tranexamic acid
for tonsillectomy included 1670 patients and concluded that
tranexamic acid did not reduce the number of patients with
post-tonsillectomy hemorrhage signiﬁcantly (p= 0.08) [16],
but the authors noted that these studies varied enormously
in the age range, dosage, schedule and duration of tranexamic
acid administration, including one paper reporting topical
application of tranexamic acid paste, resulting in a higher
bleeding rate than the placebo group [17].
Against our result, there are two studies showed that the
preoperative intravenous tranexamic acid is effective and sig-
niﬁcantly decreased the tonsillectomy bleeding [18,19]. In a
randomized controlled trial, a single dose of intravenous peri-
operative tranexamic acid at l0 mg/kg produced a mean blood
loss of 56.61 ml compared with 66.52 ml in the control group
during tonsillectomy using conventional dissection techniques
[20]. An observational study done by Robb PJ and his col-
league in pediatric found that tranexamic acid has a potential
beneﬁts to decrease bleeding after tonsillectomy, therefore they
recommended a large, prospective, multicentre, randomized
controlled trial [21].
In another study done by Robb PJ and his colleague, they
found that tranexamic acid decreased the frequency and sever-
ity of postoperative bleeding following tonsillectomy but this
study was done in adult patients [22]. In a double-blinded con-
trol study included forty patients, 9–18 yrs of age, and ran-
domized to either tranexamic acid (initial dose of 10 mg/kg
and infusion of 1 mg/kg/h) or placebo (isotonic saline).
Tranexamic acid reduced signiﬁcantly the total blood loss
and the total amount of blood transfused in the perioperative
period (p= 0.045), but this study was done in pediatric scolio-
sis surgery [23].The present study and the other studies are showing differ-
ent results regarding the effect of tranexamic acid in decreasing
the bleeding associated with tonsillectomy as some authors
found that tranexamic acid is effective in decreasing tonsillec-
tomy, while others showing no beneﬁts from tranexamic acid
and this may be related to many factors such as age of patients,
route, dose, duration of administration, surgical techniques of
tonsillectomy and number of patients in the studies. Other
studies documented the effectiveness of tranexamic acid in
the presence of ﬁbrinolysis during cardiac surgery and car-
diopulmonary bypass [24,25], neurosurgery [26,27], prostatec-
tomy [28,29], and other surgeries, while there are no studies
measured the ﬁbrinolytic activity during tonsillectomy. This
means that the tranexamic acid may be more effective to
decrease the bleeding due to ﬁbrinolysis, while it is not effective
in other surgery without ﬁbrinolysis.
There are limitations to the present study. First, small study
populations of the present study, and second the ﬁbrinolytic
activity during tonsillectomy were not measured as the kits
for measurement were not available in the laboratory.
5. Conclusion
The present study showed no effect of tranexamic acid in
decreasing the tonsillectomy-related bleeding and there is no
complication related to tranexamic acid. Other studies are rec-
ommended to measure the ﬁbrinolytic activity during tonsillec-
tomy and its inhibition by tranexamic acid.
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